Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07604363
High-Fidelity Simulation and Longitudinal Outcomes in Novice Nurses (HFS-NOVA)Tri-Service General HospitalCompletedNot Applicable
NCT07604363Completed
Not Applicable
High-Fidelity Simulation and Longitudinal Outcomes in Novice Nurses (HFS-NOVA)Tri-Service General Hospi...
NCT07604519
Multi-Ingredient Supplementation in Professional Football PlayersVizja University in WarsawNot Yet RecruitingNot Applicable
NCT07604519Not Yet Recruiting
Not Applicable
Multi-Ingredient Supplementation in Professional Football PlayersVizja University in Warsa...
NCT07605117
Isoinertial Training in Patients With COPDUniversidad Manuela BeltránNot Yet RecruitingNot Applicable
NCT07605117Not Yet Recruiting
Not Applicable
Isoinertial Training in Patients With COPDUniversidad Manuela Beltr...
NCT07602738
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.Al-Azhar UniversityCompletedPhase 3
NCT07602738Completed
Phase 3
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment fo...Al-Azhar University
NCT07604168
Effect of Coordinated Locomotor Training on Lumbopelvic Stability and Pain in Runners With Mechanical Low Back PainUniversity of FaisalabadCompletedNot Applicable
NCT07604168Completed
Not Applicable
Effect of Coordinated Locomotor Training on Lumbopelvic Stability and Pain in Ru...University of Faisalabad
NCT07601620
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast CancerShanghai Henlius BiotechNot Yet RecruitingPhase 1
NCT07601620Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-...Shanghai Henlius Biotech
NCT07602361
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and ObesityUniversidad Autonoma de Baja CaliforniaActive Not RecruitingNot Applicable
NCT07602361Active Not Recruiting
Not Applicable
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweig...Universidad Autonoma de B...
NCT07601295
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)National Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingPhase 2
NCT07601295Not Yet Recruiting
Phase 2
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of P...National Heart, Lung, and...
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07605234
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients With Hematolymphoid MalignanciesTata Memorial HospitalNot Yet RecruitingNot Applicable
NCT07605234Not Yet Recruiting
Not Applicable
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Ph...Tata Memorial Hospital
NCT07602231
Effectiveness of Enhanced Recovery After Surgery (ERAS) Protocols for Arthroscopic Anterior Cruciate Ligament Reconstruction in an Ambulatory Surgery SettingUniversity Medical Center Ho Chi Minh City (UMC)Not Yet RecruitingNot Applicable
NCT07602231Not Yet Recruiting
Not Applicable
Effectiveness of Enhanced Recovery After Surgery (ERAS) Protocols for Arthroscop...University Medical Center...
NCT07604298
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic StrokeNanfang Hospital, Southern Medical UniversityNot Yet Recruiting
NCT07604298Not Yet Recruiting
—
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Tre...Nanfang Hospital, Souther...
NCT07605065
Dexamethasone Plus Metoclopramide Versus Paracetamol/NSAIDs for Primary HeadachePak Emirates Military HospitalNot Yet RecruitingPhase 4
NCT07605065Not Yet Recruiting
Phase 4
Dexamethasone Plus Metoclopramide Versus Paracetamol/NSAIDs for Primary HeadachePak Emirates Military Hos...
NCT07604194
Embolosclerotherapy Versus Deep Dorsal Vein Revascularization in Venogenic Erectile DysfunctionMansoura University HospitalNot Yet RecruitingNot Applicable
NCT07604194Not Yet Recruiting
Not Applicable
Embolosclerotherapy Versus Deep Dorsal Vein Revascularization in Venogenic Erect...Mansoura University Hospi...
NCT07601334
Safety and Activity of HF50 in Patients With Advanced Solid TumorsHighField Biopharmaceuticals CorporationNot Yet RecruitingPhase 1
NCT07601334Not Yet Recruiting
Phase 1
Safety and Activity of HF50 in Patients With Advanced Solid TumorsHighField Biopharmaceutic...
NCT07605195
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep LearningYunnan Cancer HospitalNot Yet RecruitingNot Applicable
NCT07605195Not Yet Recruiting
Not Applicable
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Bre...Yunnan Cancer Hospital
NCT07603869
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2026European Society of CardiologyCompleted
NCT07603869Completed
—
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2...European Society of Cardi...
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07603570
Endovenous Laser Ablation With 1940 nm Versus 1470 nmKafrelsheikh UniversityActive Not RecruitingPhase 3
NCT07603570Active Not Recruiting
Phase 3
Endovenous Laser Ablation With 1940 nm Versus 1470 nmKafrelsheikh University
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Active, not recruiting2 (10%)
Recruiting2 (10%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 32 (10%)
Phase 12 (10%)
Phase 22 (10%)
Phase 41 (5%)